Friess Associates LLC Coll Plant Biotechnologies LTD Transaction History
Friess Associates LLC
- $59.9 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
2.05MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD490KShares$1.51 Million0.03% of portfolio
-
Villere St Denis J & CO LLC484KShares$1.5 Million0.17% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.43 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$854,1682.69% of portfolio
-
Brown Advisory Inc119KShares$369,1460.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $34.3M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...